Two new compounds, baccataxinine (1) and baccalignan (2), were isolated from the Taxus baccata, together with 16 known ones. Their structures were elucidated by comprehensive spectroscopic analyses of HR-ESI-MS, NMR and IR. Compound 1 is a taxane diterpenoid possessing a rare dioxolane ring between C-1 and C-2, while 2 is the first benzofuran neolignan from this species. Furthermore, they were also evaluated for their α-glucosidase inhibitory activity, but none of them showed considerable inhibitory effects.
The genus Taxus, covering eleven species in the world, are classified as endangered species listed by the host countries [1] . It has been revealed by many reports that taxus plants exhibit antitumor, anti-inflammatory, antibacterial, hepatoprotective, analgesic, hypoglycemic and other pharmacological activities [2] . The discovery of taxol, which is widely used in clinical treatment of ovarian, breast, lung, and other cancers [3] [4] [5] , makes this genus a research hotspot. Additionally, the hypoglycemic effect of this genus has achieved great progress in the past two years [6] [7] [8] .
Owing to the prominent and diverse biological activities of natural products in this genus, investigations on chemical compositions and pharmacological activities of them are still a reliable way to discover new lead compounds.
Taxus baccata (European yew), widely distributed in Europe, north region of Middle East, and Asia minor [9] , is one of the major poisonous plants. It is a kind of small to medium-sized evergreen tree that has been historically used for weapon-making and medicine [10] . Various types of chemical components, like taxanes, flavonoids, lignans, steroids, and sugar derivatives, have been isolated from this species. According to the pharmacological study, taxane diterpenoids are the major bioactive components of this plant [11] . In continuing investigations on the natural bioactive compounds of T. baccata, we have isolated and identified two new compounds, baccataxinine (1) and baccalignan (2), as well as 16 known taxane diterpenoids. Their structures were elucidated by the means of HR-ESI-MS, IR and NMR. Compound 1 is determined to be a taxane diterpenoid with an unusual dioxolane moiety. Compound 2 is the first benzofuran neolignan from this species. Besides, all the compounds were evaluated for α-glucosidase inhibitory activity. Herein, we reported the isolation, structural determination and bioactivity in detail.
The chromatographic and crystallization separation of the CH 2 Cl 2 extract of T. baccata resulted in the purification of 18 compounds, including two new compounds with different structural types, baccataxinine (1) and baccalignan (2) . The known compounds were identified as taxinine B (3) [12] , O-cinnamoyltaxicin I (4) [13] , O(5)-cinnamoyltaxicin I triacetate (5) [13] , taxinine (6) [13] , decinnamoyltaxinine E (7) [14] , taxinine E (8) [15] , 1β,2α,9α-trihydroxy-10β-acetoxy-5α-cinnamoyloxy-3,11-cyclotaxa-4(20)-en-13-one (9) 1-hydroxytaxuspine C (11) [18] , taxagifine (12) [12] , taxacin (13) [12, 15] , taxchinin B (14) [19] , taxchinin J (15) [20] , taxin B (16) [15] , taxuspine W (17) [12, 15] , and 2α,7β,13α-triacetoxy,5α,9α-dihydroxy-2(3→20)abeotaxa-4(20),11-dien-10-one (18) [21], (Figure 1) . Considering with the above evidences, compound 1 was considered to be a taxane diterpenoid with the typical 6/8/6 ring skeleton [8] , which was further confirmed by the observation of characteristic 13 C NMR signals [δ C 43.4 (d), 44.6 (s), 41.3 (s)] (Table 1) for C-3, C-8 and C-15 in that skeleton. Comparing the NMR data of 1 with those of known O(5)-cinnamoyltaxicin I triacetate (5) [13] with the same skeleton, a partial structural similarity was observed except for the presence of one trioxy-substitution carbon [δc 119.2 (s)] [22] , a methoxy and a methyl groups , and the absence of one acetoxy group at C-2. The HMBC (Figure 2 ) correlations between δ H 1.55, δ H 3.36 with the above carbon signal indicated that both of the methyl and methoxy groups were installed at that position. Moreover, the chemical shifts of C-1 and C-2 in compound 1 were downfielded by Δδ C 7.7 and 3.4 ppm, respectively. Hence, with the aforementioned information, a dioxolane ring was formed between C-1, C-2. Besides, the locations of the groups on the taxane skeleton were further confirmed by the HMBC experiment ( Figure 2) . Therefore, the planar structure of 1 was confirmed.
The NOESY correlations of H-2/17-Meβ and H-9/19-Meβ suggested that H-2 and H-9 were β-oriented. Cross-peaks between H-10/H-3α, H-10/Me-18, H-10/H-7, and H-7/H-3α indicated their α-orientation. The cinnamoyl group at C-5 was α-oriented, as deduced by the NOESY correlations between H-5 and H-9. Furthermore, the β-configuration of methoxy group was confirmed based on the NOESY correlation between H-2 and methoxy group. On the contrary, the methyl took α-orientation. Therefore, the relative configuration of 1 was assigned as shown in Figure 1 , named baccataxinine.
Compound 2 was isolated as white amorphous powder. Its molecular formula was assigned to be C 23 Furthermore, by analyzing the degree of unsaturation from the molecular formula, one furan ring should be observed. Hence, it is assumed that compound 2 was a benzofuran neolignan. The 1 H and 13 C NMR spectra of 2 resembled closely those of tiruneesiin (19) [23] (Figure 1 ) with the same skeleton ( Table 1 ), except that one of methoxy groups was replaced by hydroxy at C-7, which was further supported by the HMBC correlation between the hydroxy proton (δ H 4.84, s) and the aromatic carbon at δ C 139.9 (s). The location of methoxy group was determined to be at C-3' from the HMBC spectrum (Figure 2) . Based on the interpretation of HMBC spectrum, the location of two acetoxy, hydroxy, and methoxy groups were further confirmed. Thus, this new compound was deduced to be baccalignan (2) as depicted in Figure 1 .
All isolated compounds were evaluated for their α-glucosidase inhibitory activity in vitro using a previously described protocol. However, no compounds showed remarkable α-glucosidase inhibitory effects. (1-1, 1-2, 1-3 ). Subfraction 1-1 was rechromatographed with PE-EtOAc, followed by preparative MPLC with MeOH-H 2 O (30% to 70%) to give 5 (217.0 mg) and 6 (121.3 mg), while subfraction 1-2 was also rechromatographed with PE-EtOAc, followed by preparative HPLC with MeOH-H 2 O (75%) to give 8 (17 mg) and 11 (3.5 mg). Compounds 1 (7.8 mg) was isolated from the fraction 1-3 by preparative HPLC (MeOH-H 2 O, 80% to 90%). Fractions 2 was further separated by silica gel column chromatography repeatedly with different developing solvent (CH 2 Cl 2 -MeOH, PE-EtOAc, PE-acetone), and finally compounds 9 (12.8 mg), 17 (3.7 mg), 18 (15.7 mg) and new compound 2 (5.1 mg) were separated in pure form. Fraction 4 and 5 were subjected to silica gel column chromatography, eluted with PE-EtOAc to afford 2 known compounds 4 (2.6 mg) and 7 (3.0 mg). Fractions 6 and 7 were individually separated by silica gel column chromatography eluted with CH 2 Cl 2 -MeOH to give 10 (6.6 mg) and 15 (25.9 mg), respectively. Assay for α-glucosidase activity: α-Glucosidase activity was assayed according to the reported method [8, 24] 
